-- Scott Roberts
THURSDAY, March 1 (HealthDay News) -- Two drugs that supplement
the digestion-aiding actions of pancreatic enzymes have been
approved by the U.S. Food and Drug Administration, the agency said
Thursday in a news release.
Ultresa (pancrelipase) was approved for adults and children with
cystic fibrosis and other disorders that affect food digestion
because the pancreas does not produce enough enzymes, the FDA
The second drug, Viokace (pancrelipase), is to be used in
combination with a proton pump inhibiting medication to treat
adults with pancreatitis -- a chronic inflammation of the pancreas.
This drug's safety and effectiveness have not been established in
children, the agency said.
About 200,000 people in the United States have "pancreatic
insufficiency" disorders, according to the FDA. The two new
medications are the 4th and 5th to be approved for these
Both new drugs are produced by Aptalis Pharma US, based in
Medline Plus has more about
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.